Active Ingredient History
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea. While it has seen off-label use as a purported cognitive enhancer to improve wakefulness in animal and human studies, the research on its effectiveness for this use is not conclusive. Modafinil is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alcoholism (Phase 2)
Alcohol-Related Disorders (Phase 2)
Alzheimer Disease (Phase 4)
Amphetamine-Related Disorders (Phase 2)
Apathy (Phase 3)
Apnea (Phase 2)
Attention (Phase 4)
Bipolar Disorder (Phase 4)
Body Fluids (Phase 1)
Brain Injuries (Phase 1/Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Cataplexy (Phase 3)
Cocaine-Related Disorders (Phase 3)
Cognition (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Deglutition Disorders (Phase 2)
Delayed Emergence from Anesthesia (Phase 4)
Delirium (Phase 3)
Depression (Phase 4)
Depressive Disorder, Major (Phase 3)
Disorders of Excessive Somnolence (Phase 3)
Drug Administration Schedule (Phase 1)
Drug Therapy (Phase 2)
Executive Function (Phase 4)
Fatigue (Phase 4)
Healthy Volunteers (Phase 4)
HIV Infections (Phase 4)
Hypotension, Orthostatic (Phase 1)
Idiopathic Hypersomnia (Phase 2)
Infusions, Intravenous (Phase 1)
Liver Cirrhosis, Biliary (Phase 1)
Melanoma (Phase 1)
Memory, Short-Term (Phase 4)
Mental Health (Phase 4)
Methamphetamine (Phase 4)
Modafinil (Early Phase 1)
Mood Disorders (Early Phase 1)
Multiple Sclerosis (Phase 4)
Narcolepsy (Phase 3)
Neoplasms (Phase 3)
Neurobehavioral Manifestations (Phase 1)
Opioid-Related Disorders (Phase 2)
Orthostatic Intolerance (Phase 2)
Osteoarthritis (Phase 4)
Pain (Phase 3)
Parkinson Disease (Phase 2)
Postpoliomyelitis Syndrome (Phase 3)
Postural Orthostatic Tachycardia Syndrome (Early Phase 1)
Prostatic Neoplasms (Phase 3)
Psychotic Disorders (Phase 4)
Pure Autonomic Failure (Phase 1)
Quality of Life (Phase 3)
Respiratory Insufficiency (Phase 3)
Schizophrenia (Phase 4)
Sleep Apnea, Obstructive (Phase 4)
Sleep Apnea Syndromes (Phase 1)
Sleep Deprivation (Phase 1)
Sleep Disorders, Circadian Rhythm (Phase 3)
Sleep Disorders, Intrinsic (Phase 3)
Sleep Wake Disorders (Phase 3)
Spatial Processing (Phase 2)
Stress Disorders, Post-Traumatic (Phase 2/Phase 3)
Stroke (Phase 3)
Substance-Related Disorders (Phase 2)
Tachycardia (Phase 1/Phase 2)
Tinnitus (Phase 1)
Tobacco Use Disorder (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
